Antibiotic resistance—the need for global solutions

2013, Vital signs: carbapenem-resistant Enterobacteriaceae, MMWR Morb Mortal Wkly Rep, 62, 165 Laxminarayan, 2012, Challenges of drug resistance in the developing world, BMJ, 344, e1567, 10.1136/bmj.e1567 Abraham, 1988, An enzyme from bacteria able to destroy penicillin. 1940, Rev Infect Dis, 10, 677 Davies, 2010, Origins and evolution of antibiotic resistance, Microbiol Mol Biol Rev, 74, 417, 10.1128/MMBR.00016-10 Holmes, 1967, Studies of venereal disease. I. Probenecid-procaine penicillin G combination and tetracycline hydrochloride in the treatment of “penicillin-resistant” gonorrhea in men, JAMA, 202, 461, 10.1001/jama.1967.03130190067008 Rasnake, 2005, History of U.S. military contributions to the study of sexually transmitted diseases, Mil Med, 170, 61, 10.7205/MILMED.170.4S.61 Nordmann, 2011, Global spread of Carbapenemase-producing Enterobacteriaceae, Emerg Infect Dis, 17, 1791, 10.3201/eid1710.110655 Walsh, 2011, Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study, Lancet Infect Dis, 11, 355, 10.1016/S1473-3099(11)70059-7 Ruiz, 2012, Transferable mechanisms of quinolone resistance, Int J Antimicrob Agents, 40, 196, 10.1016/j.ijantimicag.2012.02.011 Holden, 2013, A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic, Genome Res, 23, 653, 10.1101/gr.147710.112 Ammerlaan, 2013, Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infection, Clin Infect Dis, 56, 798, 10.1093/cid/cis1006 Allegranzi, 2011, Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis, Lancet, 377, 228, 10.1016/S0140-6736(10)61458-4 Zaidi, 2005, Hospital-acquired neonatal infections in developing countries, Lancet, 365, 1175, 10.1016/S0140-6736(05)71881-X Waters, 2011, Aetiology of community-acquired neonatal sepsis in low and middle income countries, J Glob Health, 1, 154 Viswanathan, 2012, Profile of neonatal septicaemia at a district-level sick newborn care unit, J Health Popul Nutr, 30, 41, 10.3329/jhpn.v30i1.11274 Saleem, 2010, Pan-resistant Acinetobacter infection in neonates in Karachi, Pakistan, J Infect Dev Ctries, 4, 30, 10.3855/jidc.533 Perry, 2011, Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media, J Antimicrob Chemother, 66, 2288, 10.1093/jac/dkr299 Khan, 2010, Increased isolation of ESBL producing Klebsiella pneumoniae with emergence of carbapenem resistant isolates in Pakistan: report from a tertiary care hospital, J Pak Med Assoc, 60, 186 Perovic O, Singh-Moodley A, Smith M, Lowman W. Antimicrobial resistance of Klebsiella pneumoniae and Staphylococcus aureus at sentinel sites in South Africa. 52nd interscience conference on antimicrobial agents and chemotherapy; San Francisco; Sept 9–12, 2012. Lowman, 2011, NDM-1 has arrived: first report of a carbapenem resistance mechanism in South Africa, S Afr Med J, 101, 873 2012, Update on carbapenemase-producing Enterobacteriaceae, NICD Communicable Diseases Communiqué, 12, 5 Hollyway, 2009 Datta, 2012, A ten year analysis of multi-drug resistant blood stream infections caused by Escherichia coli and Klebsiella pneumoniae in a tertiary care hospital, Indian J Med Res, 135, 907 Ko, 2007, High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea, J Antimicrob Chemother, 60, 1163, 10.1093/jac/dkm305 Capone, 2013, High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality, Clin Microbiol Infect, 19, 23, 10.1111/1469-0691.12070 Kontopidou, 2011, Colonization and infection by colistin-resistant Gram-negative bacteria in a cohort of critically ill patients, Clin Microbiol Infect, 17, 9, 10.1111/j.1469-0691.2011.03649.x Antoniadou, 2007, Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster, J Antimicrob Chemother, 59, 786, 10.1093/jac/dkl562 Baadani, 2013, Prevalence of colistin and tigecycline resistance in Acinetobacter baumannii clinical isolates from 2 hospitals in Riyadh Region over a 2-year period, Saudi Med J, 34, 248 Napier, 2013, Clinical use of colistin induces cross-resistance to host antimicrobials in Acinetobacter baumannii, MBio, 4, e00021, 10.1128/mBio.00021-13 Klein, 2013, The changing epidemiology of methicillin-resistant Staphylococcus aureus in the United States: a national observational study, Am J Epidemiol, 177, 666, 10.1093/aje/kws273 Anupurba, 2003, Prevalence of methicillin resistant Staphylococcus aureus in a tertiary referral hospital in eastern Uttar Pradesh, Indian J Med Microbiol, 21, 49 Zafar, 2011, Prevalent genotypes of meticillin-resistant Staphylococcus aureus: report from Pakistan, J Med Microbiol, 60, 56, 10.1099/jmm.0.022707-0 Malik, 2009, Frequency and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus, J Coll Physicians Surg Pak, 19, 287 Klevens, 2007, Invasive methicillin-resistant Staphylococcus aureus infections in the United States, JAMA, 298, 1763, 10.1001/jama.298.15.1763 Lambert, 2011, Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study, Lancet Infect Dis, 11, 30, 10.1016/S1473-3099(10)70258-9 Wolkewitz, 2011, Mortality associated with in-hospital bacteraemia caused by Staphylococcus aureus: a multistate analysis with follow-up beyond hospital discharge, J Antimicrob Chemother, 66, 381, 10.1093/jac/dkq424 de Kraker, 2011, Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe, PLoS Med, 8, e1001104, 10.1371/journal.pmed.1001104 Kayange, 2010, Predictors of positive blood culture and deaths among neonates with suspected neonatal sepsis in a tertiary hospital, Mwanza-Tanzania, BMC Pediatr, 10, 39, 10.1186/1471-2431-10-39 1995 Reed, 2001, Socioeconomic issues related to antibiotic use, 41 Holmberg, 1987, Health and economic impacts of antimicrobial resistance, Rev Infect Dis, 9, 1065, 10.1093/clinids/9.6.1065 The Genesis Report. The real war on drugs: bacteria are winning. New Jersey; December 1994. Howard, 2002, The Impact of resistance on antibiotic demand in patients with ear infections, 119 O'Brien, 2009, Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates, Lancet, 374, 893, 10.1016/S0140-6736(09)61204-6 Gu, 2013, The emerging problem of linezolid-resistant Staphylococcus, J Antimicrob Chemother, 68, 4, 10.1093/jac/dks354 Patel, 2013, Linezolid resistance in Enterococcus faecium isolated in Ontario, Canada, Diagn Microbiol Infect Dis, 10.1016/j.diagmicrobio.2013.08.012 López-Salas, 2013, Virulence and antibiotic resistance of Enterococcus faecalis clinical isolates recovered from three states of mexico. Detection of linezolid resistance, Arch Med Res, 44, 422, 10.1016/j.arcmed.2013.07.003 Laxminarayan, 2007 Smith, 2013, The true cost of antimicrobial resistance, BMJ, 346, 1493, 10.1136/bmj.f1493 Goossens, 2005, Outpatient antibiotic use in Europe and association with resistance: a cross-national database study, Lancet, 365, 579, 10.1016/S0140-6736(05)70799-6 Braykov, 2013, Trends in resistance to carbapenems and third-generation cephalosporins among clinical isolates of Klebsiella pneumoniae in the United States, 1999–2010, Infect Control Hosp Epidemiol, 34, 259, 10.1086/669523 Klein, 2007, Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999–2005, Emerg Infect Dis, 13, 1840, 10.3201/eid1312.070629 Steinman, 2003, Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care, JAMA, 289, 719, 10.1001/jama.289.6.719 Nitzan, 2010, Variability in outpatient antimicrobial consumption in Israel, Infection, 38, 12, 10.1007/s15010-009-9065-8 Filippini, 2006, Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland, Health Policy, 78, 77, 10.1016/j.healthpol.2005.09.009 Glass, 2010, Canadian province-level risk factor analysis of macrolide consumption patterns (2000–2006), J Antimicrob Chemother, 65, 148, 10.1093/jac/dkp391 Matuz, 2006, Regional variations in community consumption of antibiotics in Hungary, 1996–2003, Br J Clin Pharmacol, 61, 96, 10.1111/j.1365-2125.2005.02525.x Morgan, 2011, Non-prescription antimicrobial use worldwide: a systematic review, Lancet Infect Dis, 11, 692, 10.1016/S1473-3099(11)70054-8 Sweidan, 2005 Dong, 1999, Association between health insurance and antibiotics prescribing in four counties in rural China, Health Policy, 48, 29, 10.1016/S0168-8510(99)00026-3 Bennett Apisarnthanarak, 2008, Nonjudicious dispensing of antibiotics by drug stores in Pratumthani, Thailand, Infect Control Hosp Epidemiol, 29, 572, 10.1086/587496 Wise, 2002, Antimicrobial resistance: priorities for action, J Antimicrob Chemother, 49, 585, 10.1093/jac/49.4.585 Glad, 2010, Bacterial diversity in faeces from polar bear (Ursus maritimus) in Arctic Svalbard, BMC Microbiol, 10, 10, 10.1186/1471-2180-10-10 Levy, 1976, Spread of antibiotic-resistant plasmids from chicken to chicken and from chicken to man, Nature, 260, 40, 10.1038/260040a0 Harrison, 2013, Whole genome sequencing identifies zoonotic transmission of MRSA isolates with the novel mecA homologue mecC, EMBO Mol Med, 5, 509, 10.1002/emmm.201202413 Fleming, 1946 Kunin, 1974, This is medical progress? Trends and consequences of antibiotic use in the United States. In comment, JAMA, 227, 1030, 10.1001/jama.1974.03230220020004 Hranjec, 2012, Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study, Lancet Infect Dis, 12, 774, 10.1016/S1473-3099(12)70151-2 Thriemer, 2013, Antibiotic prescribing in DR Congo: a knowledge, attitude and practice survey among medical doctors and students, PLoS ONE, 8, e55495, 10.1371/journal.pone.0055495 Stone, 2012, Evaluation of the national Cleanyourhands campaign to reduce Staphylococcus aureus bacteraemia and Clostridium difficile infection in hospitals in England and Wales by improved hand hygiene: four year, prospective, ecological, interrupted time series study, BMJ, 344, e3005, 10.1136/bmj.e3005 Schwaber, 2011, Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention, Clin Infect Dis, 52, 848, 10.1093/cid/cir025 Brinsley, 2005, Implementation of the Campaign to Prevent Antimicrobial Resistance in Healthcare Settings: 12 steps to prevent antimicrobial resistance among hospitalized adults-experiences from 3 institutions, Am J Infect Control, 33, 53, 10.1016/j.ajic.2004.12.003 Ghafur, 2013, The Chennai Declaration: a roadmap to tackle the challenge of antimicrobial resistance, Indian J Cancer, 50, 71, 10.4103/0019-509X.104065 Gould IM, Wang GH, Wu J-J, et al. Global burden of multi drug resistant organisms current antimicrobial resistance problems in the Asia-Pacific. MDRO Beijing Consensus Meeting Report. J Global Antimicrob Resistance (in press). Paterson, 2006, The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals, Clin Infect Dis, 42, 90, 10.1086/499407 Lawes, 2012, Trends in Staphylococcus aureus bacteraemia and impacts of infection control practices including universal MRSA admission screening in a hospital in Scotland, 2006–2010: retrospective cohort study and time-series intervention analysis, BMJ Open, 2, 3, 10.1136/bmjopen-2011-000797 Vernaz, 2009, Temporal effects of antibiotic use and Clostridium difficile infections, J Antimicrob Chemother, 63, 1272, 10.1093/jac/dkp128 Dellit, 2007, Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship, Clin Infect Dis, 44, 159, 10.1086/510393 Nabyonga Orem, 2012, Do guidelines influence the implementation of health programs? Uganda's experience, Implement Sci, 7, 98, 10.1186/1748-5908-7-98 Wertheim, 2013, Providing impetus, tools, and guidance to strengthen national capacity for antimicrobial stewardship in Viet Nam, PLoS Med, 10, e1001429, 10.1371/journal.pmed.1001429 Millar, 2012, Constraining the use of antibiotics: applying Scanlon's contractualism, J Med Ethics, 38, 465, 10.1136/medethics-2011-100256 Apisarnthanarak, 2009, Comparison of methods of measuring pharmacy sales of antibiotics without prescriptions in Pratumthani, Thailand, Infect Control Hosp Epidemiol, 30, 1130, 10.1086/647980 Radyowijati, 2003, Improving antibiotic use in low-income countries: an overview of evidence on determinants, Soc Sci Med, 57, 733, 10.1016/S0277-9536(02)00422-7 Thorgeirsson, 2013, Behavioral economics: merging psychology and economics for lifestyle interventions, Am J Prev Med, 44, 185, 10.1016/j.amepre.2012.10.008 Sumpradit, 2012, Antibiotics Smart Use: a workable model for promoting the rational use of medicines in Thailand, Bull World Health Organ, 90, 905, 10.2471/BLT.12.105445 2008, Antibiotic overuse: the influence of social norms, J Am Coll Surg, 207, 265, 10.1016/j.jamcollsurg.2008.02.035 MacDougall, 2005, Antimicrobial stewardship programs in health care systems, Clin Microbiol Rev, 18, 638, 10.1128/CMR.18.4.638-656.2005 Choi S, Reich M. Report cards and prescribing behavior: assessing the impacts of public disclosure on antibiotic prescribing rates in South Korea. Third International Conference in Improving Use of Medicines; Antalya, Turkey; Nov14–18, 2011. 13 AD. Masiero, 2010, Socioeconomic determinants of outpatient antibiotic use in Europe, Int J Public Health, 55, 469, 10.1007/s00038-010-0167-y Mintzes B. Pharmaceutical promotion and prevention of antibiotic resistance. Mastering anti-infective therapies. Paris: 2005. Hawkings, 2008, Antibiotics in the community: a typology of user behaviours, Patient Educ Couns, 73, 146, 10.1016/j.pec.2008.05.025 Grigoryan, 2008, Determinants of self-medication with antibiotics in Europe: the impact of beliefs, country wealth and the healthcare system, J Antimicrob Chemother, 61, 1172, 10.1093/jac/dkn054 Planta, 2007, The role of poverty in antimicrobial resistance, J Am Board Fam Med, 20, 533, 10.3122/jabfm.2007.06.070019 Zarb, 2012, Human use of antimicrobial agents, Rev Sci Tech, 31, 121, 10.20506/rst.31.1.2108 Wirtz, 2010, Trends in antibiotic utilization in eight Latin American countries, 1997-2007, Rev Panam Salud Publica, 27, 219, 10.1590/S1020-49892010000300009 Earnshaw, 2009, European Antibiotic Awareness Day, 2008–the first Europe-wide public information campaign on prudent antibiotic use: methods and survey of activities in participating countries, Euro Surveill, 14, 19280, 10.2807/ese.14.30.19280-en Blozik, 2012, Telemedicine can help to ensure that patients receive timely medical care, J Telemed Telecare, 18, 119, 10.1258/jtt.2011.110812 Minzi, 2013, Application of basic pharmacology and dispensing practice of antibiotics in accredited drug-dispensing outlets in Tanzania, Drug Healthc Patient Saf, 5, 5, 10.2147/DHPS.S36409 Pulcini, 2013, How to educate prescribers in antimicrobial stewardship practices, Virulence, 4, 192, 10.4161/viru.23706 Laxminarayan, 2011, Communicating trends in resistance using a drug resistance index, BMJ Open, 1, e000135, 10.1136/bmjopen-2011-000135 Huttner, 2010, Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries, Lancet Infect Dis, 10, 17, 10.1016/S1473-3099(09)70305-6 Park, 2011, Advances in microfluidic PCR for point-of-care infectious disease diagnostics, Biotechnol Adv, 29, 830, 10.1016/j.biotechadv.2011.06.017 Diekema, 2013, Rapid detection of antibiotic-resistant organism carriage for infection prevention, Clin Infect Dis, 56, 1614, 10.1093/cid/cit038 Galar, 2012, Clinical and economic evaluation of the impact of rapid microbiological diagnostic testing, J Infect, 65, 302, 10.1016/j.jinf.2012.06.006 Kerremans, 2008, Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use, J Antimicrob Chemother, 61, 428, 10.1093/jac/dkm497 Cantón, 2011, Emergence and spread of antibiotic resistance following exposure to antibiotics, FEMS Microbiol Rev, 35, 977, 10.1111/j.1574-6976.2011.00295.x Johnson, 2012, Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years, J Antimicrob Chemother, 67, 802, 10.1093/jac/dkr561 Okeke, 2011 2003 2007 Bouki, 2013, Detection and fate of antibiotic resistant bacteria in wastewater treatment plants: a review, Ecotoxicol Environ Saf, 91, 1, 10.1016/j.ecoenv.2013.01.016 Shi, 2013, Metagenomic insights into chlorination effects on microbial antibiotic resistance in drinking water, Water Res, 47, 111, 10.1016/j.watres.2012.09.046 Davey, 2013, Interventions to improve antibiotic prescribing practices for hospital inpatients, Cochrane Database Syst Rev, 4, 10.1002/14651858.CD003543.pub3 DeNap, 2005, Bacterial death comes full circle: targeting plasmid replication in drug-resistant bacteria, Org Biomol Chem, 3, 959, 10.1039/b500182j Kurinčič, 2012, Epigallocatechin gallate as a modulator of Campylobacter resistance to macrolide antibiotics, Int J Antimicrob Agents, 40, 467, 10.1016/j.ijantimicag.2012.07.015 Potera, 2013, Phage renaissance: new hope against antibiotic resistance, Environ Health Perspect, 121, a48, 10.1289/ehp.121-a48 Allerberger, 2009, Antibiotic stewardship implementation in the EU: the way forward, Expert Rev Anti Infect Ther, 7, 1175, 10.1586/eri.09.96 Bodansky Cantón, 2012, Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe, Clin Microbiol Infect, 18, 413, 10.1111/j.1469-0691.2012.03821.x Butler, 2009, Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries, BMJ, 338, 2242, 10.1136/bmj.b2242 Little, 2013, Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial, Lancet Infect Dis, 13, 123, 10.1016/S1473-3099(12)70300-6 Kang, 2003, Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome, Clin Infect Dis, 37, 745, 10.1086/377200 Ishengoma, 2009, Health laboratories in the Tanga region of Tanzania: the quality of diagnostic services for malaria and other communicable diseases, Ann Trop Med Parasitol, 103, 441, 10.1179/136485909X451726 Kreft, 2013, PCR is changing clinical diagnostics, Microbe, 8, 15 Ritzi-Lehnert, 2012, Development of chip-compatible sample preparation for diagnosis of infectious diseases, Expert Rev Mol Diagn, 12, 189, 10.1586/erm.11.98 Okeke, 2011, Diagnostics as essential tools for containing antibacterial resistance, Drug Resist Updat, 14, 95, 10.1016/j.drup.2011.02.002 Peeling, 2008, A guide for diagnostic evaluations, Nat Rev Microbiol, 6, 2, 10.1038/nrmicro1522 Loens, 2006, Two quality control exercises involving nucleic acid amplification methods for detection of Mycoplasma pneumoniae and Chlamydophila pneumoniae and carried out 2 years apart (in 2002 and 2004), J Clin Microbiol, 44, 899, 10.1128/JCM.44.3.899-908.2006 Loens, 2012, Performance of different mono- and multiplex nucleic acid amplification tests on a multipathogen external quality assessment panel, J Clin Microbiol, 50, 977, 10.1128/JCM.00200-11 World Economic Forum. The financial sustainability of health systems. A case for change. 2012. Loens, 2009, Optimal sampling sites and methods for detection of pathogens possibly causing community-acquired lower respiratory tract infections, J Clin Microbiol, 47, 21, 10.1128/JCM.02037-08 Gazin, 2012, Current trends in culture-based and molecular detection of extended-spectrum-β-lactamase-harboring and carbapenem-resistant Enterobacteriaceae, J Clin Microbiol, 50, 1140, 10.1128/JCM.06852-11 Livermore, 2012, Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?, J Antimicrob Chemother, 67, 1569, 10.1093/jac/dks088 Falagas, 2012, Impact of antibiotic MIC on infection outcome in patients with susceptible Gram-negative bacteria: a systematic review and meta-analysis, Antimicrob Agents Chemother, 56, 4214, 10.1128/AAC.00663-12 Little, 2013, Effects of internet-based training on antibioitic prescribing rates for acute respiratory-tract infection: a multinational, cluster, randomised, factorial, controlled trial, Lancet, 382, 175, 10.1016/S0140-6736(13)60994-0 Mitsuma, 2013, Promising new assays and technologies for the diagnosis and management of infectious diseases, Clin Infect Dis, 56, 996, 10.1093/cid/cis1014 Nicks, 2009, The Centers for Medicare and Medicaid Services (CMS) community-acquired pneumonia core measures lead to unnecessary antibiotic administration by emergency physicians, Acad Emerg Med, 16, 184, 10.1111/j.1553-2712.2008.00320.x Stokstad, 1949, Further observations on the animal protein factor, Proc Soc Biol Exp Med, 73, 523, 10.3181/00379727-73-17731 Swedish Ministry of Agriculture. Antimicrobial feed additives. Report from the commission on antimicrobial feed additives. Stockholm, 1997.139. Robinson, 1952, Controlled trial of aureomycin in premature twins and triplets, Lancet, 259, 52, 10.1016/S0140-6736(52)91020-9 Swann, 1969 Grave, 2006, Usage of veterinary therapeutic antimicrobials in Denmark, Norway and Sweden following termination of antimicrobial growth promoter use, Prev Vet Med, 75, 123, 10.1016/j.prevetmed.2006.02.003 Marshall, 2011, Food animals and antimicrobials: impacts on human health, Clin Microbiol Rev, 24, 718, 10.1128/CMR.00002-11 Witte, 2000, Selective pressure by antibiotic use in livestock, Int J Antimicrob Agents, 16, 19, 10.1016/S0924-8579(00)00301-0 Aarestrup, 2010, Changes in the use of antimicrobials and the effects on productivity of swine farms in Denmark, Am J Vet Res, 71, 726, 10.2460/ajvr.71.7.726 Pagel, 2012, Use of antimicrobial agents in livestock, Rev Sci Tech, 31, 145, 10.20506/rst.31.1.2106 2013, The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2011, EFSA J, 11, 3196, 10.2903/j.efsa.2013.3196 Kruse, 1994, Transfer of multiple drug resistance plasmids between bacteria of diverse origins in natural microenvironments, Appl Environ Microbiol, 60, 4015, 10.1128/AEM.60.11.4015-4021.1994 Wellington, 2013, The role of the natural environment in the emergence of antibiotic resistance in gram-negative bacteria, Lancet Infect Dis, 13, 155, 10.1016/S1473-3099(12)70317-1 Catry, 2010, Reflection paper on MRSA in food-producing and companion animals: epidemiology and control options for human and animal health, Epidemiol Infect, 138, 626, 10.1017/S0950268810000014 Holmberg, 1984, Drug-resistant Salmonella from animals fed antimicrobials, N Engl J Med, 311, 617, 10.1056/NEJM198409063111001 Hald, 2007, The attribution of human infections with antimicrobial resistant Salmonella bacteria in Denmark to sources of animal origin, Foodborne Pathog Dis, 4, 313, 10.1089/fpd.2007.0002 Nordstrom, 2013, Foodborne urinary tract infections: a new paradigm for antimicrobial-resistant foodborne illness, Front Microbiol, 4, 29, 10.3389/fmicb.2013.00029 Chee-Sanford, 2009, Fate and transport of antibiotic residues and antibiotic resistance genes following land application of manure waste, J Environ Qual, 38, 1086, 10.2134/jeq2008.0128 Chaslus-Dancla, 2000, Spread of resistance from food animals to man: the French experience, Acta Vet Scand Suppl, 93, 53 Lester, 2006, In vivo transfer of the vanA resistance gene from an Enterococcus faecium isolate of animal origin to an E. faecium isolate of human origin in the intestines of human volunteers, Antimicrob Agents Chemother, 50, 596, 10.1128/AAC.50.2.596-599.2006 Seiffert, 2013, Extended-spectrum cephalosporin-resistant Gram-negative organisms in livestock: an emerging problem for human health?, Drug Resist Updat, 16, 22, 10.1016/j.drup.2012.12.001 Leverstein-van Hall, 2011, Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains, Clin Microbiol Infect, 17, 873, 10.1111/j.1469-0691.2011.03497.x Börjesson, 2013, Characterization of plasmid-mediated AmpC-producing E. coli from Swedish broilers and association with human clinical isolates, Clin Microbiol Infect, 19, 309, 10.1111/1469-0691.12192 Fischer, 2013, Salmonella enterica subsp. enterica producing VIM-1 carbapenemase isolated from livestock farms, J Antimicrob Chemother, 68, 478, 10.1093/jac/dks393 Ashbolt, 2013, Human Health Risk Assessment (HHRA) for environmental development and transfer of antibiotic resistance, Environ Health Perspect, 121, 993, 10.1289/ehp.1206316 Smith, 2002, Animal antibiotic use has an early but important impact on the emergence of antibiotic resistance in human commensal bacteria, Proc Natl Acad Sci USA, 99, 6434, 10.1073/pnas.082188899 Bowen, 2013, Antimicrobial stewardship: Time for change, Equine Vet J, 45, 127, 10.1111/evj.12041 Cars, 2008, Meeting the challenge of antibiotic resistance, BMJ, 337, a1438, 10.1136/bmj.a1438 Carlet, 2012, Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action, Antimicrob Resist Infect Control, 1, 11, 10.1186/2047-2994-1-11 1987, 67 Li, 2012, Overprescribing in China, driven by financial incentives, results in very high use of antibiotics, injections, and corticosteroids, Health Aff (Millwood), 31, 1075, 10.1377/hlthaff.2010.0965 Bigdeli, 2013, Access to medicines from a health system perspective, Health Policy Plan, 28, 692, 10.1093/heapol/czs108 So, 2011, Towards new business models for R&D for novel antibiotics, Drug Resist Updat, 14, 88, 10.1016/j.drup.2011.01.006 So, 2012, 3Rs for innovating novel antibiotics: sharing resources, risks, and rewards, BMJ, 344, e1782, 10.1136/bmj.e1782 Morones-Ramirez, 2013, Silver enhances antibiotic activity against gram-negative bacteria, Sci Transl Med, 5, 190ra81, 10.1126/scitranslmed.3006276 Fischbach, 2011, Combination therapies for combating antimicrobial resistance, Curr Opin Microbiol, 14, 519, 10.1016/j.mib.2011.08.003 Cottarel, 2007, Combination drugs, an emerging option for antibacterial therapy, Trends Biotechnol, 25, 547, 10.1016/j.tibtech.2007.09.004 Mishra, 2012, Vaccines and antibiotic resistance, Curr Opin Microbiol, 15, 596, 10.1016/j.mib.2012.08.002 Goodman 2011 Boehme, 2010, Rapid molecular detection of tuberculosis and rifampin resistance, N Engl J Med, 363, 1005, 10.1056/NEJMoa0907847 Lim, 2006, Reducing the global burden of acute lower respiratory infections in children: the contribution of new diagnostics, Nature, 444, 9, 10.1038/nature05442 Rinaldi Mitjà, 2012, Single-dose azithromycin versus benzathine benzylpenicillin for treatment of yaws in children in Papua New Guinea: an open-label, non-inferiority, randomised trial, Lancet, 379, 342, 10.1016/S0140-6736(11)61624-3 Michel, 2006, Field evaluation of a rapid point-of-care assay for targeting antibiotic treatment for trachoma control: a comparative study, Lancet, 367, 1585, 10.1016/S0140-6736(06)68695-9 Johansson, 2012 Baqui, 2004, Zinc therapy for diarrhoea increased the use of oral rehydration therapy and reduced the use of antibiotics in Bangladeshi children, J Health Popul Nutr, 22, 440 Rutschmann, 2004, Antibiotics for upper respiratory tract infections in ambulatory practice in the United States, 1997–1999: does physician specialty matter?, J Am Board Fam Pract, 17, 196, 10.3122/jabfm.17.3.196 Shapiro, 2013, Antibiotic prescribing for adults in ambulatory care in the USA, 2007–09, J Antimicrob Chemother Mainous, 2009, Availability of antibiotics for purchase without a prescription on the internet, Ann Fam Med, 7, 431, 10.1370/afm.999 Blomberg, 2007, Antimicrobial resistance predicts death in Tanzanian children with bloodstream infections: a prospective cohort study, BMC Infect Dis, 7, 43, 10.1186/1471-2334-7-43 Siegel, 2003, Treatment of otitis media with observation and a safety-net antibiotic prescription, Pediatrics, 112, 527, 10.1542/peds.112.3.527 Schiff, 2001, Improving inpatient antibiotic prescribing: insights from participation in a national collaborative, Jt Comm J Qual Improv, 27, 387, 10.1016/S1070-3241(01)27033-3 Otrompke Bisoffi, 2009, Rapid malaria diagnostic tests vs. clinical management of malaria in rural Burkina Faso: safety and effect on clinical decisions. A randomized trial, Trop Med Int Health, 14, 491, 10.1111/j.1365-3156.2009.02246.x Bastiaens, 2011, Malaria diagnostic testing and treatment practices in three different Plasmodium falciparum transmission settings in Tanzania: before and after a government policy change, Malar J, 10, 76, 10.1186/1475-2875-10-76 Batwala, 2011, Antibiotic use among patients with febrile illness in a low malaria endemicity setting in Uganda, Malar J, 10, 377, 10.1186/1475-2875-10-377 Nanyonjo, 2012, Community acceptability and adoption of integrated community case management in Uganda, Am J Trop Med Hyg, 87, 97, 10.4269/ajtmh.2012.11-0763 Mukanga, 2012, Integrated community case management of fever in children under five using rapid diagnostic tests and respiratory rate counting: a multi-country cluster randomized trial, Am J Trop Med Hyg, 87, 21, 10.4269/ajtmh.2012.11-0816 Hamer, 2012, Quality and safety of integrated community case management of malaria using rapid diagnostic tests and pneumonia by community health workers, Pathog Glob Health, 106, 32, 10.1179/1364859411Y.0000000042 Waters, 2004, Economic evaluation of Mectizan distribution, Trop Med Int Health, 9, 16, 10.1111/j.1365-3156.2004.01210.x Sturchio, 2001, The case of ivermectin: lessons and implications for improving access to care and treatment in developing countries, Community Eye Health, 14, 22 Trehan, 2013, Antibiotics as part of the management of severe acute malnutrition, N Engl J Med, 368, 425, 10.1056/NEJMoa1202851 Bole Rinaldi Khadem, 2012, Antimicrobial stewardship: a matter of process or outcome?, Pharmacotherapy, 32, 688, 10.1002/j.1875-9114.2012.01154.x Kilo, 1998, A framework for collaborative improvement: lessons from the Institute for Healthcare Improvement's Breakthrough Series, Qual Manag Health Care, 6, 1, 10.1097/00019514-199806040-00001 2012 Nugent, 2010 O'Brien, 2002, Emergence, spread, and environmental effect of antimicrobial resistance: how use of an antimicrobial anywhere can increase resistance to any antimicrobial anywhere else, Clin Infect Dis, 34, 78, 10.1086/340244 Liu, 2012, Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000, Lancet, 379, 2151, 10.1016/S0140-6736(12)60560-1 Okeke, 2005, Antimicrobial resistance in developing countries. Part II: strategies for containment, Lancet Infect Dis, 5, 568, 10.1016/S1473-3099(05)70217-6 Monjur, 2010, Antibiotic sensitivity pattern of causative organisms of neonatal septicemia in an urban hospital of Bangladesh, Indian J Med Sci, 64, 265, 10.4103/0019-5359.99605 Nepal, 2013, Bacteriological profile of neonatal septicemia cases and the antimicrobial resistance pattern in a tertiary care hospital of central Nepal, Internat J Biomed Research, 4, 26 Shitaye, 2010, Risk factors and etiology of neonatal sepsis in Tikur Anbessa University Hospital, Ethiopia, Ethiop Med J, 48, 11 Chiabi, 2011, The clinical and bacteriogical spectrum of neonatal sepsis in a tertiary hospital in yaounde, cameroon, Iran J Pediatr, 21, 441 Acquah, 2013, Susceptibility of bacterial etiological agents to commonly-used antimicrobial agents in children with sepsis at the Tamale Teaching Hospital, BMC Infect Dis, 13, 89, 10.1186/1471-2334-13-89 Viswanathan, 2012, Multi-drug resistant gram negative bacilli causing early neonatal sepsis in India, Archives of Dis in Childhood-Fetal and Neonatal Ed, 97, 182, 10.1136/archdischild-2011-300097 Muhammad, 2010, Neonatal sepsis: causative bacteria and their resistance to antibiotics. Journal of Ayub Medical College, J Ayub Med Coll Abbottabad, 22, 33 Awoniyi, 2009, An epidemiological survey of neonatal sepsis in a hospital in Western Nigeria, Afr J Microbiol Research, 3, 385 Al-Shamahy, 2012, Types of Bacteria associated with Neonatal Sepsis in Al-Thawra University Hospital, Sana'a, Yemen, and their Antimicrobial Profile, Sultan Qaboos Univ Med J, 12, 48, 10.12816/0003087 Kruse, 2013, Neonatal bloodstream infections in a pediatric hospital in Vietnam: a cohort study, J Trop Pediatr, 10.1093/tropej/fmt056 Elham, 2011, Retrospective analysis of neonatal bacteremia and antimicrobial resistance pattern in neonatal intensive care unit, Res J Med Med Sci, 6, 62 Zaidi, 2009, Pathogens associated with sepsis in newborns and young infants in developing countries, Pediatr Infect Dis J, 28, 10, 10.1097/INF.0b013e3181958769 West, 2012, Sensitivity pattern among bacterial isolates in neonatal septicaemia in port Harcourt, Ann Clin Microbiol Antimicrob, 11, 7, 10.1186/1476-0711-11-7 Lubell, 2011, Susceptibility of community-acquired pathogens to antibiotics in Africa and Asia in neonates–an alarmingly short review, Trop Med Int Health, 16, 145, 10.1111/j.1365-3156.2010.02686.x Lynch, 2009, Streptococcus pneumoniae: does antimicrobial resistance matter?, Semin Respir Crit Care Med, 30, 210, 10.1055/s-0029-1202939 Zafar, 2008, Antibiotic susceptibility of pathogens isolated from patients with community-acquired respiratory tract infections in Pakistan–the active study. Journal of Ayub Medical College, J Ayub Med Coll Abbottabad, 20, 7 Borg, 2009, Prevalence of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae isolates reported by laboratories in the southern and eastern Mediterranean region, Clin Microbiol Infect, 15, 232, 10.1111/j.1469-0691.2008.02651.x Benouda, 2009, Antimicrobial resistance of respiratory pathogens in North African countries, J Chemother, 21, 627, 10.1179/joc.2009.21.6.627 Tali-Maamar, 2012, Serotyping and antibiotic susceptibility of Streptococcus pneumoniae strains isolated in Algeria from 2001 to 2010, Med Mal Infect, 42, 59, 10.1016/j.medmal.2011.12.001 Agudelo, 2009, Resistance to non-beta-lactam antibiotics in the clinical isolates of Streptococcus pneumoniae of children in Latin America. SIREVA II, 2000-2005, Rev Panam Salud Publica, 25, 305, 10.1590/S1020-49892009000400004 Arifeen, 2009, Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance, Clin Infect Dis, 48, 103, 10.1086/596543 Lozano, 2012, Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010, Lancet, 380, 2095, 10.1016/S0140-6736(12)61728-0 Abera, 2010, Antimicrobial suceptibility of V. cholerae in north west, Ethiopia, Ethiop Med J, 48, 23 Balaji, 2013, Virulence and multidrug resistance patterns of Vibrio cholerae O1 isolates from diarrheal outbreaks of South India during 2006–2009, Microb Drug Resist, 19, 198, 10.1089/mdr.2012.0127 Karki, 2011, Resistotypes of Vibrio cholerae 01 Ogawa Biotype El Tor in Kathmandu, Nepal, Nepal Med Coll J, 13, 84 Marin, 2013, Cholera outbreaks in Nigeria are associated with multidrug resistant atypical El Tor and non-O1/non-O139 Vibrio cholerae, PLoS Negl Trop Dis, 7, e2049, 10.1371/journal.pntd.0002049 Sang, 2012, Prevalence and antibiotic resistance of bacterial pathogens isolated from childhood diarrhoea in four provinces of Kenya, J Infect Dev Ctries, 6, 572, 10.3855/jidc.2196 Kiiru, 2009, Molecular characterisation of Vibrio cholerae O1 strains carrying an SXT/R391-like element from cholera outbreaks in Kenya: 1994–2007, BMC Microbiol, 9, 275, 10.1186/1471-2180-9-275 Mwansa, 2007, Multiply antibiotic-resistant Vibrio cholerae O1 biotype El Tor strains emerge during cholera outbreaks in Zambia, Epidemiol Infect, 135, 847, 10.1017/S0950268806007254 Rashed, 2012, Genetic characteristics of drug-resistant Vibrio cholerae O1 causing endemic cholera in Dhaka, 2006-2011, J Med Microbiol, 61, 1736, 10.1099/jmm.0.049635-0 Charles, 2011, Cholera in the 21st century, Curr Opin Infect Dis, 24, 472, 10.1097/QCO.0b013e32834a88af Borkakoty, 2012, Emergence of classical ctxB genotype 1 and tetracycline resistant strains of Vibrio cholerae O1 El Tor in Assam, India, Trans R Soc Trop Med Hyg, 106, 382, 10.1016/j.trstmh.2012.03.005 Shakoor, 2012, Tropical bacterial gastrointestinal infections, Infect Dis Clin North Am, 26, 437, 10.1016/j.idc.2012.02.002 Gu, 2012, Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of Shigella between Europe-America and Asia-Africa from 1998 to 2009, Int J Antimicrob Agents, 40, 9, 10.1016/j.ijantimicag.2012.02.005 Ghosh, 2011, Genetic characteristics and changing antimicrobial resistance among Shigella spp. isolated from hospitalized diarrhoeal patients in Kolkata, India, J Med Microbiol, 60, 1460, 10.1099/jmm.0.032920-0 Ahmed, 2012, Bacterial aetiology of diarrhoeal diseases and antimicrobial resistance in Dhaka, Bangladesh, 2005–2008, Epidemiol Infect, 140, 1678, 10.1017/S0950268811002135 Okeke, 2005, Antimicrobial resistance in developing countries. Part I: recent trends and current status, Lancet Infect Dis, 5, 481, 10.1016/S1473-3099(05)70189-4 Shea, 2004, Nontherapeutic use of antimicrobial agents in animal agriculture: implications for pediatrics, Pediatrics, 114, 862, 10.1542/peds.2004-1233 Srikantiah, 2006, Population-based surveillance of typhoid fever in Egypt, Am J Trop Med Hyg, 74, 114, 10.4269/ajtmh.2006.74.114 Kumar, 2008, Rising prevalence of enteric fever due to multidrug-resistant Salmonella: an epidemiological study, J Med Microbiol, 57, 1247, 10.1099/jmm.0.2008/001719-0 Khan, 2012, Epidemiology, clinical presentation, and patterns of drug resistance of Salmonella Typhi in Karachi, Pakistan, J Infect Dev Ctries, 6, 704, 10.3855/jidc.1967 Lunguya, 2012, Salmonella typhi in the democratic republic of the congo: fluoroquinolone decreased susceptibility on the rise, PLoS Negl Trop Dis, 6, e1921, 10.1371/journal.pntd.0001921 Kariuki, 2010, Typhoid in Kenya is associated with a dominant multidrug-resistant Salmonella enterica serovar Typhi haplotype that is also widespread in Southeast Asia, J Clin Microbiol, 48, 2171, 10.1128/JCM.01983-09 Mills-Robertson, 2002, Molecular characterization of antibiotic resistance in clinical Salmonella typhi isolated in Ghana, FEMS Microbiol Lett, 215, 249, 10.1111/j.1574-6968.2002.tb11398.x Molyneux, 2000, Salmonella meningitis in children in Blantyre, Malawi, 1996–1999, Ann Trop Paediatr, 20, 41, 10.1080/02724930092057 Tabu, 2012, Differing burden and epidemiology of non-Typhi Salmonella bacteremia in rural and urban Kenya, 2006–2009, PLoS One, 7, e31237, 10.1371/journal.pone.0031237 Feasey, 2012, Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa, Lancet, 379, 2489, 10.1016/S0140-6736(11)61752-2 Kariuki, 2006, Characterisation of community acquired non-typhoidal Salmonella from bacteraemia and diarrhoeal infections in children admitted to hospital in Nairobi, Kenya, BMC Microbiol, 6, 101, 10.1186/1471-2180-6-101 Gordon, 2008, Epidemics of invasive Salmonella enterica serovar enteritidis and S. enterica Serovar typhimurium infection associated with multidrug resistance among adults and children in Malawi, Clin Infect Dis, 46, 963, 10.1086/529146 Kingsley, 2009, Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype, Genome Res, 19, 2279, 10.1101/gr.091017.109 Bachou, 2006, Bacteraemia among severely malnourished children infected and uninfected with the human immunodeficiency virus-1 in Kampala, Uganda, BMC Infect Dis, 6, 160, 10.1186/1471-2334-6-160 Ikumapayi, 2007, Molecular epidemiology of community-acquired invasive non-typhoidal Salmonella among children aged 2 29 months in rural Gambia and discovery of a new serovar, Salmonella enterica Dingiri, J Med Microbiol, 56, 1479, 10.1099/jmm.0.47416-0 Vandenberg, 2010, Microbiologic and clinical features of Salmonella species isolated from bacteremic children in eastern Democratic Republic of Congo, Pediatr Infect Dis J, 29, 504, 10.1097/INF.0b013e3181cd615a Lunguya, 2013, Antimicrobial resistance in invasive non-typhoid Salmonella from the Democratic Republic of the Congo: emergence of decreased fluoroquinolone susceptibility and extended-spectrum beta lactamases, PLoS Negl Trop Dis, 7, e2103, 10.1371/journal.pntd.0002103 Menezes, 2010, Molecular characterization of antimicrobial resistance in non-typhoidal salmonellae associated with systemic manifestations from India, J Med Microbiol, 59, 1477, 10.1099/jmm.0.022319-0 Byarugaba, 2004, A view on antimicrobial resistance in developing countries and responsible risk factors, Int J Antimicrob Agents, 24, 105, 10.1016/j.ijantimicag.2004.02.015 Paruk, 2012, Antibiotic prescription practices and their relationship to outcome in South Africa: findings of the prevalence of infection in South African intensive care units (PISA) study, S Afr Med J, 102, 613, 10.7196/SAMJ.5833 Datta, 2012, A ten year analysis of multi-drug resistant blood stream infections caused by Escherichia coli & Klebsiella pneumoniae in a tertiary care hospital, Indian J Med Res, 135, 907 Rosenthal, 2010, Impact of International Nosocomial Infection Control Consortium (INICC) strategy on central line-associated bloodstream infection rates in the intensive care units of 15 developing countries, Infect Control Hosp Epidemiol, 31, 1264, 10.1086/657140 Laxminarayan, 2006, Drug resistance, 1031 Byarugaba, 2005, Antimicrobial resistance and its containment in developing countries, 617 Ashley, 2011, Antimicrobial susceptibility of bacterial isolates from community acquired infections in Sub-Saharan Africa and Asian low and middle income countries, Trop Med Int Health, 16, 1167, 10.1111/j.1365-3156.2011.02822.x Downie, 2013, Community-acquired neonatal and infant sepsis in developing countries: efficacy of WHO's currently recommended antibiotics-systematic review and meta-analysis, Arch Dis Child, 98, 146, 10.1136/archdischild-2012-302033 Nugent, 2004, Food and agriculture policy: issues related to prevention of noncommunicable diseases, Food Nutr Bull, 25, 200, 10.1177/156482650402500214 Nugent Nugent, 2010, When medicines fail: recommendations for curbing antibiotic resistance, J Infect Dev Ctries, 4, 355, 10.3855/jidc.1211 2006 Raka, 2010, Prevention and Control of Hospital-Related Infections in Low and Middle Income Countries, Open Infect Dis J, 4, 125, 10.2174/1874279301004020125 Goossens, 2013, The Chennai declaration on antimicrobial resistance in India, Lancet Infect Dis, 13, 105, 10.1016/S1473-3099(12)70346-8 Leung, 2011, The WHO policy package to combat antimicrobial resistance, Bull World Health Organ, 89, 390, 10.2471/BLT.11.088435 Nishtar, 2010 Lewis Koziol Freedominfo.org. Mexico. Freedom of information. http://www.freedominfo.org/regions/latin-america/mexico/mexico2/. (accessed Aug 13, 2013). Ramkumar, 2008 2004 Fraser, 2005, Implementing electronic medical record systems in developing countries, Inform Prim Care, 13, 83 Dagan, 2009, Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae, Clin Microbiol Infect, 15, 16, 10.1111/j.1469-0691.2009.02726.x Ganguly, 2011, Rationalizing antibiotic use to limit antibiotic resistance in India, Indian J Med Res, 134, 281 Levin, 2011, Role of the private sector in the provision of immunization services in low- and middle-income countries, Health Policy Plan, 26, 4, 10.1093/heapol/czr037 Joice, 2013, Targeting imperfect vaccines against drug-resistance determinants: a strategy for countering the rise of drug resistance, PLoS One, 8, e68940, 10.1371/journal.pone.0068940 Gouws, 2004, Improving antimicrobial use among health workers in first-level facilities: results from the multi-country evaluation of the Integrated Management of Childhood Illness strategy, Bull World Health Organ, 82, 509 Contessotto Spadetto, 2000, Rational use of antibiotics in pediatrics: impact of a rapid test for detection of beta-haemolytic group A streptococci in acute pharyngotonsillitis, An Esp Pediatr, 52, 212, 10.1016/S1695-4033(00)77325-5 Coates, 2011, Novel classes of antibiotics or more of the same?, Br J Pharmacol, 163, 184, 10.1111/j.1476-5381.2011.01250.x Powers, 2004, Antimicrobial drug development—the past, the present, and the future, Clin Microbiol Infect, 10, 23, 10.1111/j.1465-0691.2004.1007.x Fenton, 2004, Daptomycin, Drugs, 64, 445, 10.2165/00003495-200464040-00009 Zappia, 2007, The contribution of oxazolidinone frame to the biological activity of pharmaceutical drugs and natural products, Mini Rev Med Chem, 7, 389, 10.2174/138955707780363783 Boucher, 2009, Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America, Clin Infect Dis, 48, 1, 10.1086/595011 Coates, 2012, Antibiotics in phase II and III clinical trials, Handb Exp Pharmacol, 211, 167, 10.1007/978-3-642-28951-4_11 Bax, 2012, Introduction to antibiotic resistance, Handb Exp Pharmacol, 211, 1, 10.1007/978-3-642-28951-4_1 Hernandez, 2013, Discovery of a novel class of boron-based antibacterials with activity against gram-negative bacteria, Antimicrob Agents Chemother, 57, 1394, 10.1128/AAC.02058-12 Chen, 2013, Emerging resistance problems and future perspectives in pharmacotherapy for complicated urinary tract infections, Expert Opin Pharmacother, 14, 587, 10.1517/14656566.2013.778827 Kahlmeter, 2012, Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited, Int J Antimicrob Agents, 39, 45, 10.1016/j.ijantimicag.2011.09.013 Widerström, 2011, Near absence of methicillin-resistance and pronounced genetic diversity among Staphylococcus epidermidis isolated from healthy persons in northern Sweden, APMIS, 119, 505, 10.1111/j.1600-0463.2011.02757.x Mossialos McKenna Bergström, 2011, The role of the pharmaceutical industry in meeting the public health threat of antibacterial resistance, Drug Resist Updat, 14, 77, 10.1016/j.drup.2011.01.005 Haverfield Spellberg 2010, The 10 × '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020, Clin Infect Dis, 50, 1081, 10.1086/652237 Davies Towse, 2011, Incentives for R&D for new antimicrobial drugs, Int J Econ Bus, 18, 331, 10.1080/13571516.2011.584434 2012, White paper: recommendations on the conduct of superiority and organism-specific clinical trials of antibacterial agents for the treatment of infections caused by drug-resistant bacterial pathogens, Clin Infect Dis, 55, 1031, 10.1093/cid/cis688 Goldfarb, 2006, Clinical operations: accelerating trials, allocating resources and measuring performance, J Clin Res Best Practices, 2, 12 Coates, 2012, Antibiotic discovery, Pan European Networks: Science and Technology, 4, 1 Tralau-Stewart, 2009, Drug discovery: new models for industry-academic partnerships, Drug Discov Today, 14, 95, 10.1016/j.drudis.2008.10.003 Jenks, 2012, New NIH center broadens scope of translational research, J Natl Cancer Inst, 104, 728, 10.1093/jnci/djs247 Williams, 2012, Collaborative approaches to anticancer drug discovery and development: a Cancer Research UK perspective, Drug Discov Today, 17, 185, 10.1016/j.drudis.2012.01.020 Cohen, 2013, Infectious disease. Approval of novel TB drug celebrated–with restraint, Science, 339, 130, 10.1126/science.339.6116.130 Coates Ballell, 2013, Fueling open-source drug discovery: 177 small-molecule leads against tuberculosis, ChemMedChem, 8, 313, 10.1002/cmdc.201200428 Cooper, 2011, Fix the antibiotics pipeline, Nature, 472, 32, 10.1038/472032a Fernebro, 2011, Fighting bacterial infections-future treatment options, Drug Resist Updat, 14, 125, 10.1016/j.drup.2011.02.001 Bartlett, 2006, Narrative review: the new epidemic of Clostridium difficile-associated enteric disease, Ann Intern Med, 145, 758, 10.7326/0003-4819-145-10-200611210-00008 Rex, 2013, A comprehensive regulatory framework to address the unmet need for new antibacterial treatments, Lancet Infect Dis, 13, 269, 10.1016/S1473-3099(12)70293-1 Payne, 2007, Drugs for bad bugs: confronting the challenges of antibacterial discovery, Nat Rev Drug Discov, 6, 29, 10.1038/nrd2201 Bérdy, 2005, Bioactive microbial metabolites, J Antibiot (Tokyo), 58, 1, 10.1038/ja.2005.1 Bérdy, 2012, Thoughts and facts about antibiotics: where we are now and where we are heading, J Antibiot (Tokyo), 65, 385, 10.1038/ja.2012.27 Donald, 2009, A Staphylococcus aureus fitness test platform for mechanism-based profiling of antibacterial compounds, Chem Biol, 16, 826, 10.1016/j.chembiol.2009.07.004 Eisenstein, 2010, Daptomycin: from the mountain to the clinic, with essential help from Francis Tally, MD, Clin Infect Dis, 50, 10, 10.1086/647938 Brown, 2013, Is the GAIN Act a turning point in new antibiotic discovery?, Can J Microbiol, 59, 153, 10.1139/cjm-2013-0089 Kalan, 2011, Antibiotic adjuvants: multicomponent anti-infective strategies, Expert Rev Mol Med, 13, 5, 10.1017/S1462399410001766 Drawz, 2010, Three decades of beta-lactamase inhibitors, Clin Microbiol Rev, 23, 160, 10.1128/CMR.00037-09 Hugonnet, 2009, Meropenem-clavulanate is effective against extensively drug-resistant Mycobacterium tuberculosis, Science, 323, 1215, 10.1126/science.1167498 Shlaes, 2013, New β-lactam-β-lactamase inhibitor combinations in clinical development, Ann N Y Acad Sci, 1277, 105, 10.1111/nyas.12010 Shakya, 2011, A small molecule discrimination map of the antibiotic resistance kinome, Chem Biol, 18, 1591, 10.1016/j.chembiol.2011.10.018 Lomovskaya, 2006, Practical applications and feasibility of efflux pump inhibitors in the clinic–a vision for applied use, Biochem Pharmacol, 71, 910, 10.1016/j.bcp.2005.12.008 Ejim, 2011, Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy, Nat Chem Biol, 7, 348, 10.1038/nchembio.559 Spitzer, 2011, Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole, Mol Syst Biol, 7, 499, 10.1038/msb.2011.31 Farha, 2013, Inhibition of WTA synthesis blocks the cooperative action of PBPs and sensitizes MRSA to β-lactams, ACS Chem Biol, 8, 226, 10.1021/cb300413m Rogers, 2010, Synergistic effects between conventional antibiotics and 2-aminoimidazole-derived antibiofilm agents, Antimicrob Agents Chemother, 54, 2112, 10.1128/AAC.01418-09 Wenderska, 2011, Palmitoyl-DL-carnitine is a multitarget inhibitor of Pseudomonas aeruginosa biofilm development, ChemBioChem, 12, 2759, 10.1002/cbic.201100500 Escaich, 2008, Antivirulence as a new antibacterial approach for chemotherapy, Curr Opin Chem Biol, 12, 400, 10.1016/j.cbpa.2008.06.022 Mattmann, 2010, Small molecules that modulate quorum sensing and control virulence in Pseudomonas aeruginosa, J Org Chem, 75, 6737, 10.1021/jo101237e Mansson, 2011, Inhibition of virulence gene expression in Staphylococcus aureus by novel depsipeptides from a marine photobacterium, Mar Drugs, 9, 2537, 10.3390/md9122537 Nielsen, 2010, Method for screening compounds that influence virulence gene expression in Staphylococcus aureus, Antimicrob Agents Chemother, 54, 509, 10.1128/AAC.00940-09 Hung, 2005, Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization, Science, 310, 670, 10.1126/science.1116739 Duncan, 2012, Chemical inhibitors of the type three secretion system: disarming bacterial pathogens, Antimicrob Agents Chemother, 56, 5433, 10.1128/AAC.00975-12 Turgeon, 2011, Newly discovered and characterized antivirulence compounds inhibit bacterial mono-ADP-ribosyltransferase toxins, Antimicrob Agents Chemother, 55, 983, 10.1128/AAC.01164-10 De Leon, 2006, An in vitro screen of bacterial lipopolysaccharide biosynthetic enzymes identifies an inhibitor of ADP-heptose biosynthesis, Chem Biol, 13, 437, 10.1016/j.chembiol.2006.02.010 Langsdorf, 2010, Screening for antibacterial inhibitors of the UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) using a high-throughput mass spectrometry assay, J Biomol Screen, 15, 52, 10.1177/1087057109355319 Richter, 2013, Small molecule inhibitor of lipoteichoic acid synthesis is an antibiotic for Gram-positive bacteria, Proc Natl Acad Sci USA, 110, 3531, 10.1073/pnas.1217337110 Brodin, 2010, High content phenotypic cell-based visual screen identifies Mycobacterium tuberculosis acyltrehalose-containing glycolipids involved in phagosome remodeling, PLoS Pathog, 6, e1001100, 10.1371/journal.ppat.1001100 Reichert, 2012, Marketed therapeutic antibodies compendium, MAbs, 4, 413, 10.4161/mabs.19931 Oleksiewicz, 2012, Anti-bacterial monoclonal antibodies: back to the future?, Arch Biochem Biophys, 526, 124, 10.1016/j.abb.2012.06.001 Bebbington, 2008, Antibodies for the treatment of bacterial infections: current experience and future prospects, Curr Opin Biotechnol, 19, 613, 10.1016/j.copbio.2008.10.002 Hancock, 2012, Modulating immunity as a therapy for bacterial infections, Nat Rev Microbiol, 10, 243, 10.1038/nrmicro2745 Hancock, 2006, Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies, Nat Biotechnol, 24, 1551, 10.1038/nbt1267 Easton, 2009, Potential of immunomodulatory host defense peptides as novel anti-infectives, Trends Biotechnol, 27, 582, 10.1016/j.tibtech.2009.07.004 McFarland, 2006, Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease, Am J Gastroenterol, 101, 812, 10.1111/j.1572-0241.2006.00465.x Kassam, 2013, Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis, Am J Gastroenterol, 108, 500, 10.1038/ajg.2013.59 Falup-Pecurariu, 2012, Lessons learnt after the introduction of the seven valent-pneumococcal conjugate vaccine toward broader spectrum conjugate vaccines, Biom J, 35, 450, 10.4103/2319-4170.104409 McKenna, 2012, Vaccine development: Man vs MRSA, Nature, 482, 23, 10.1038/482023a Prabowo, 2013, Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines, Med Microbiol Immunol (Berl), 202, 95, 10.1007/s00430-012-0278-6 Wernli, 2011, A call for action: the application of The International Health Regulations to the global threat of antimicrobial resistance, PLoS Med, 8, e1001022, 10.1371/journal.pmed.1001022 Grundmann, 2011, A framework for global surveillance of antibiotic resistance, Drug Resist Updat, 14, 79, 10.1016/j.drup.2011.02.007